Article Details

Bristol-Myers Shares Jump As Goldman Sachs Moves It To 'Conviction Buy' List

Retrieved on: 2020-12-15 11:26:15

Tags for this article:

Click the tags to see associated articles and topics

Bristol-Myers Shares Jump As Goldman Sachs Moves It To 'Conviction Buy' List. View article details on hiswai:

Excerpt

<b>Goldman</b> analyst Terence Flynn said FDA approvals and pipeline developments could lift Bristol-Myers sales to around $13 billion over the next four ...

Article found on: www.thestreet.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo